Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mau

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
International Journal of Environmental Research and Public Health|May 4, 2026
Improving Diagnostic Accuracy of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Through a Point-of-Care Clinical AlgorithmJaime Seltzer, Stephanie L Grach, Scott D Eggers, et al.
British Journal of Rheumatology|October 23, 1998
Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritisJ Dequeker, C Hawkey, A Kahan, et al.
British Journal of Rheumatology|October 23, 1998
Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety AssessmentC Hawkey, A Kahan, K Steinbrück, et al.
The Journal of Biological Chemistry|October 15, 1988
Chloroplast transport of a ribulose bisphosphate carboxylase small subunit-5-enolpyruvyl 3-phosphoshikimate synthase chimeric protein requires part of the mature small subunit in addition to the transit peptideL Comai, N Larson-Kelly, J Kiser, et al.
Nuklearmedizin. Nuclear Medicine|June 22, 2005
Myocardial perfusion/metabolism mismatch and ventricular arrhythmias in the chronic post infarction stateB J Krause, T D Poeppel, M Reinhardt, et al.
Neurochemical Research|March 18, 2017
Validation of a Preclinical Drug Screening Platform for Pharmacoresistant EpilepsyMelissa L Barker-Haliski, Kristina Johnson, Peggy Billingsley, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
International Journal of Environmental Research and Public Health|May 4, 2026
Improving Diagnostic Accuracy of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Through a Point-of-Care Clinical AlgorithmJaime Seltzer, Stephanie L Grach, Scott D Eggers, et al.
British Journal of Rheumatology|October 23, 1998
Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritisJ Dequeker, C Hawkey, A Kahan, et al.
British Journal of Rheumatology|October 23, 1998
Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety AssessmentC Hawkey, A Kahan, K Steinbrück, et al.
The Journal of Biological Chemistry|October 15, 1988
Chloroplast transport of a ribulose bisphosphate carboxylase small subunit-5-enolpyruvyl 3-phosphoshikimate synthase chimeric protein requires part of the mature small subunit in addition to the transit peptideL Comai, N Larson-Kelly, J Kiser, et al.
Nuklearmedizin. Nuclear Medicine|June 22, 2005
Myocardial perfusion/metabolism mismatch and ventricular arrhythmias in the chronic post infarction stateB J Krause, T D Poeppel, M Reinhardt, et al.
Neurochemical Research|March 18, 2017
Validation of a Preclinical Drug Screening Platform for Pharmacoresistant EpilepsyMelissa L Barker-Haliski, Kristina Johnson, Peggy Billingsley, et al.
Pageof 3